A court case that could open up stand-alone licensing opportunities in Florida’s vertically integrated medical marijuana market isn’t going to be decided anytime soon.



<!–

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});
–>

var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc299585 = window.plc299585 || 0;
document.write(”);
AdButler.ads.push({handler: function(opt){ AdButler.register(172085, 299585, [300,250], ‘placement_299585_’+opt.place, opt); }, opt: { place: plc299585++, keywords: abkw, domain: ‘servedbyadbutler.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});

In a rare move, the Florida Supreme Court – which held oral arguments on the issue in early May – scheduled a second set of oral arguments for Oct. 7.

Industry officials had expected a ruling this summer.

The case, filed by Tampa-based Florigrown, has been dragging on since the summer of 2018, when Leon County Circuit Judge Charles Dodson declared that licensing limits imposed by a 2017 law violated the MMJ constitutional amendment approved by Florida voters in 2016.

At one point, Dodson told Florida regulators to quit stalling and issue additional licenses, but the state instead decided to fight his ruling.

Under the current vertically integrated structure and licensing caps, a handful of operators control a Florida medical cannabis market that Marijuana Business Factbook projects will reach $775 million to $950 million in sales this year.

Florida-based Trulieve by itself has a market share exceeding 50% and operates 51 of Florida’s 258 dispensaries, according to the state’s latest weekly update.

Pure Cannabis Hemp Oil

  • Pure CBD Tincture, derived from organic, US-harvested hemp, lab-tested for quality.

  • Clinically proven therapeutic effects.

  • Relieves anxiety and stress

  • Eliminates chronic pain and aches

  • Regulates mood and sleep patterns

  • Enhances focus and clarity

pure cannabis oil

George Scorsis Liberty Health Sciences

Originally posted on via Cannabis Industry News

Author: George Scorsis

Mr. George Scorsis has more than 15 years of experience leading companies in highly regulated industries to rapid growth, including alcohol, energy drinks and, most recently, medical cannabis. Formerly CEO of Liberty Health Sciences, Mr. Scorsis leveraged his extensive background in managing growth within a highly regulated environment to expand Liberty Health Sciences Inc.’s cannabis-related platforms in the United States. Prior to joining Liberty Health Sciences, Mr. Scorsis was President of Red Bull Canada where he was instrumental in restructuring the organization from a geographical and operational perspective, growing the business to $150 MM in revenue. He also worked closely with Health Canada on guidelines regulating the energy drink category while also establishing a corporately owned distribution model in volatile markets. As the previous President at Mettrum Health Corp., a leading Canadian cannabis distributor, Mr. Scorsis contributed to the company becoming an industry leader and eventually seeing the organization sell for $ 430 MM. He also served as Chairman of the Board of Directors of Scythian Biosciences Corp., a research and development company committed to advancing treatment efforts for traumatic brain injury with its proprietary cannabinoid-based combination drug therapy and additional cannabis-related activities across the globe.

Design a site like this with WordPress.com
Get started